肝硬化合并门静脉血栓与食管静脉曲张患者的实践差异:北美调查研究
该调查向消化科和肝病科医生发放问卷,评估肝硬化合并门静脉血栓患者的抗凝与静脉曲张出血预防策略。结果显示,患者列入肝移植、有症状或存在肠系膜上静脉血栓时医生更倾向于启动抗凝;预防首次静脉曲张出血时许多医生选择非选择性β受体阻滞剂联合静脉曲张套扎;在预防首次出血的方式上存在实践差异。
要点
- 患者列入肝移植、有症状或合并肠系膜上静脉血栓时,医生更倾向于启动抗凝。
- 预防首次静脉曲张出血时,许多医生选择非选择性β受体阻滞剂联合静脉曲张套扎。
- 医生对需启动抗凝的临床场景意见一致,但预防首次静脉曲张出血的方式存在实践差异。
核心结论
- 医生对需启动抗凝的临床场景意见一致,但预防首次静脉曲张出血的方式存在实践差异。
研究设计与样本
- 向消化科和肝病科医生发放问卷调查肝硬化合并门静脉血栓患者的抗凝与静脉曲张出血预防策略。
主要发现
- 患者列入肝移植、有症状或存在肠系膜上静脉血栓时,医生更倾向于启动抗凝。
- 预防首次静脉曲张出血时,许多医生选择非选择性β受体阻滞剂联合静脉曲张套扎。
- 医生对需启动抗凝的临床场景意见一致,但预防首次静脉曲张出血的方式存在实践差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There exists variation regarding the approach to anticoagulation and variceal hemorrhage (VH) prophylaxis among patients with cirrhosis and portal vein thrombosis (PVT). METHODS: A survey was distributed to gastroenterology and hepatology providers to assess the approach to anticoagulation and VH prophylaxis among patients with PVT in cirrhotic patients. RESULTS: Providers were more likely to start anticoagulation if the patient was listed for liver transplantation, was symptomatic, or had superior mesenteric vein thrombosis. For prevention of first VH, many providers opt for combination therapy with both nonselective beta blockers and variceal ligation. DISCUSSION: Although providers agree on the clinical scenarios that merit initiation of anticoagulation, practice variation was identified in the means of preventing first VH.
引用
- Mui BG, Grinspan LT, Crismale JF, et al. Variations in Practice Among Cirrhotic Patients With Portal Vein Thrombosis and Esophageal Varices: A North American Survey Study. Am J Gastroenterol. 2023. PMID: 38147511. doi:10.14309/ajg.0000000000002640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。